Literature DB >> 15305146

Association study of PICK1 rs3952 polymorphism and schizophrenia.

Chen-Jee Hong1, Ding-Lieh Liao, Hao-Ling Shih, Shih-Jen Tsai.   

Abstract

Protein interacting with C-kinase-1 (PICKl) plays an important role in the targeting and clustering of neuronal receptors and amine transporters. The PICK1 gene may play a role in conferring susceptibility to schizophrenia as it has been mapped to chromosome 22q13.1, a region thought to contain a gene for schizophrenia. We tested the hypothesis that an allelic variant of the PICK1 gene was associated with a diagnosis of schizophrenia. The PICK1 rs3952 polymorphism was genotyped in 225 schizophrenia and 260 controls. Results demonstrated that the PICK1 rs3952 genotype and allele distribution was significantly different between the two groups. The positive association suggests that the PICK1 gene may play a role in the pathogenesis of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15305146     DOI: 10.1097/00001756-200408260-00026

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  19 in total

1.  Serine 77 in the PDZ domain of PICK1 is a protein kinase Cα phosphorylation site regulated by lipid membrane binding.

Authors:  Ina Ammendrup-Johnsen; Thor S Thorsen; Ulrik Gether; Kenneth L Madsen
Journal:  Biochemistry       Date:  2012-01-06       Impact factor: 3.162

2.  Structure of PICK1 and other PDZ domains obtained with the help of self-binding C-terminal extensions.

Authors:  Jonathan M Elkins; Evangelos Papagrigoriou; Georgina Berridge; Xiaowen Yang; Claire Phillips; Carina Gileadi; Pavel Savitsky; Declan A Doyle
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

Review 3.  Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

Authors:  Joseph T Coyle; Alo Basu; Michael Benneyworth; Darrick Balu; Glenn Konopaske
Journal:  Handb Exp Pharmacol       Date:  2012

Review 4.  Cellular and pathophysiological consequences of Arp2/3 complex inhibition: role of inhibitory proteins and pharmacological compounds.

Authors:  Sandra Chánez-Paredes; Armando Montoya-García; Michael Schnoor
Journal:  Cell Mol Life Sci       Date:  2019-05-09       Impact factor: 9.261

5.  PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor.

Authors:  Bing Zhao; Qiang Wang; Jun Du; Shiwen Luo; Jun Xia; Ye-Guang Chen
Journal:  Cell Res       Date:  2012-06-19       Impact factor: 25.617

6.  Association study of polymorphisms in glycine transporter with schizophrenia.

Authors:  S-J Tsai; C-Y Cheng; C-J Hong; D-L Liao; S-J Hou; F-C Yen; Y-J Liou
Journal:  J Neural Transm (Vienna)       Date:  2006-04-11       Impact factor: 3.575

7.  Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios.

Authors:  M Daniele Fallin; Virginia K Lasseter; Dimitrios Avramopoulos; Kristin K Nicodemus; Paula S Wolyniec; John A McGrath; Gary Steel; Gerald Nestadt; Kung-Yee Liang; Richard L Huganir; David Valle; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2005-10-28       Impact factor: 11.025

8.  Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia.

Authors:  S-J Tsai; C-J Hong; C-Y Cheng; D-L Liao; Y-J Liou
Journal:  J Neural Transm (Vienna)       Date:  2006-11-10       Impact factor: 3.575

Review 9.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

10.  PICK1 interacts with alpha7 neuronal nicotinic acetylcholine receptors and controls their clustering.

Authors:  Kristin Baer; Thomas Bürli; Kyung-Hye Huh; Andreas Wiesner; Susanne Erb-Vögtli; Dubravka Göckeritz-Dujmovic; Martijn Moransard; Atsushi Nishimune; Mark I Rees; Jeremy M Henley; Jean-Marc Fritschy; Christian Fuhrer
Journal:  Mol Cell Neurosci       Date:  2007-03-24       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.